The CD24neg subpopulation within CD44+CD24neg/low cells showed no Notch1 activation and was GSI insensitive both in 3D (spheres and soft agar colonies) and in xenografts, highlighting important therapeutic implications of heterogeneity in cancer stem cell populations. The gene discussed is CD44; the disease is cancer.